Atezolizumab Plus Bevacizumab for TACE-Unsuitable Intermediate-Stage HCC Beyond Up-To-7 Criteria: Final Analysis of REPLACEMENT
阿特珠单抗联合贝伐珠单抗治疗不适合经TACE治疗且超出Up-To-7标准的中晚期肝细胞癌:REPLACEMENT研究的最终分析
期刊:Liver International
影响因子:5.2
doi:10.1111/liv.70379
Ueshima, Kazuomi; Tsuchiya, Kaoru; Yamashita, Tatsuya; Shimose, Shigeo; Numata, Kazushi; Kodama, Yuzo; Itoh, Shinji; Tanaka, Yasuhito; Kuroda, Hidekatsu; Ohkawa, Kazuyoshi; Kuzuya, Teiji; Ikeda, Masafumi; Kooka, Youhei; Aikata, Hiroshi; Hiraoka, Atsushi; Moriguchi, Michihisa; Tateishi, Ryosuke; Ogasawara, Sadahisa; Yamamoto, Kouji; Kudo, Masatoshi